Live Earnings Conference Call: Cipher Pharmaceuticals will host a live Q2 2026 earnings call on August 12, 2026 at 8:30AM ET. TSE:CPH Cipher Pharmaceuticals Q2 2026 Earnings Report C$17.95 +0.38 (+2.16%) As of 08/11/2026 04:00 PM Eastern ProfileEarnings HistoryForecast Live Call not available Upcoming EventEarnings Conference CallCipher Pharmaceuticals Q2 202600:00 / 00:00Live Transcript Follow Audio Cipher Pharmaceuticals EPS ResultsActual EPSC$0.21Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ACipher Pharmaceuticals Revenue ResultsActual Revenue$17.14 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ACipher Pharmaceuticals Announcement DetailsQuarterQ2 2026Date8/11/2026TimeAfter Market ClosesConference Call DateWednesday, August 12, 2026Conference Call Time8:30AM ETConference Call ResourcesPress ReleaseEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release Cipher Pharmaceuticals Earnings HeadlinesCipher Pharmaceuticals Schedules Q2 2026 Earnings Release and Conference CallJuly 31, 2026 | finance.yahoo.comCipher Pharmaceuticals Announces Results of Annual General Meeting of ShareholdersJune 18, 2026 | finance.yahoo.comTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now. | Altimetry (Ad)Why The Cipher Pharmaceuticals (TSX:CPH) Story Is Shifting As Analysts Lift Valuation TargetsMay 23, 2026 | finance.yahoo.comResults: Cipher Pharmaceuticals Inc. Beat Earnings Expectations And Analysts Now Have New ForecastsMay 11, 2026 | finance.yahoo.comCipher Pharmaceuticals Announces Normal Course Issuer BidMay 1, 2026 | finance.yahoo.comSee More Cipher Pharmaceuticals Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Cipher Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cipher Pharmaceuticals and other key companies, straight to your email. Email Address About Cipher PharmaceuticalsCipher Pharmaceuticals (TSE:CPH) (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.View Cipher Pharmaceuticals ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Rocket Lab’s Record Quarter Still Left Investors Waiting on NeutronAtlassian Just Pulled Off the Software Comeback Wall Street WantedAST SpaceMobile Earnings Just Reminded Investors How Risky Space Can BeMeta’s Muse Glimmer Release Reframes Its AI Spending BetNVIDIA’s Rally Sets Up a Bigger Test Ahead of EarningsCaterpillar’s Blowout Quarter May Point to More Industrial WinnersOklo’s Revenue Transition Gives Bulls a New Reason to Watch Upcoming Earnings Brookfield (8/13/2026)NU (8/13/2026)Applied Materials (8/13/2026)BHP Group (8/17/2026)Palo Alto Networks (8/17/2026)Home Depot (8/18/2026)Medtronic (8/18/2026)Keysight Technologies (8/18/2026)Lowe's Companies (8/19/2026)TJX Companies (8/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
